Indication-based pricing for Novartis’ CAR-T cell therapy Kymriah … – Business Insider
Business Insider |
Indication-based pricing for Novartis' CAR-T cell therapy Kymriah …
Business Insider A cutting-edge new cancer treatment just got approved to treat more people with certain blood cancers last week. The second approval came with a different price. Controlling CAR-T: How scientists plan to make the engineered T … Kymriah Gets Expanded Approval for Large B-Cell Lymphoma |
